Virus de la gripe
Los inhibidores del virus de la gripe son compuestos que interfieren con la replicación y propagación de los virus de la gripe. Estos inhibidores son vitales en la investigación de estrategias antivirales, la comprensión del ciclo de vida del virus de la gripe y el desarrollo de tratamientos y vacunas eficaces. Los inhibidores de la gripe pueden dirigirse a varias etapas del proceso de replicación viral, incluyendo la entrada viral, la replicación y la liberación. En CymitQuimica, ofrecemos una amplia gama de inhibidores de alta calidad del virus de la gripe para apoyar su investigación en virología, enfermedades infecciosas y desarrollo de medicamentos antivirales.
Se han encontrado 296 productos de "Virus de la gripe"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Thymalfasin
CAS:<p>Thymalfasin (Thymosin α1) (thymosin-alpha 1) is an immunomodulating agent able to enhance the Thl immune response.</p>Fórmula:C129H215N33O55Pureza:95.36%Forma y color:White PowderPeso molecular:3108.28Picroside II
CAS:<p>Picroside II (Vanilloyl catalpol) is the main active ingredient in iridoid glycosides.</p>Fórmula:C23H28O13Pureza:98% - 99.83%Forma y color:SolidPeso molecular:512.46Tulobuterol hydrochloride
CAS:<p>Tulobuterol hydrochloride (Hokunalin) is a long-acting beta2-adrenergic receptor agonist.</p>Fórmula:C12H19Cl2NOPureza:99.24% - >99.99%Forma y color:Appearance White Crystalline PowderPeso molecular:264.19Oseltamivir
CAS:<p>Oseltamivir (GS 4104) is an orally active and highly potent viral neuraminidase (NA) with antiviral activity, inhibits A/H3N2, A/H1N2, A/H1N1 and influenza B viruses, and can be used in studies of influenza and pneumonia.</p>Fórmula:C16H28N2O4Pureza:99.28%Forma y color:SolidPeso molecular:312.4Navivumab
CAS:<p>Navivumab (CT-P23) is a monoclonal antibody targeting influenza A's HA stem, neutralizing H1, H2, H5, and H9 viruses.</p>Forma y color:LiquidLesofavumab
CAS:<p>Lesofavumab (MHAB5553A) is a human IgG1κ anti- influenza B virus antibody [1] .</p>Forma y color:LiquidDiridavumab
CAS:<p>Diridavumab: monoclonal antibody, stabilizes HA, blocks fusion in endosomes, used for H2 influenza research.</p>Forma y color:LiquidFirivumab
CAS:<p>Firivumab, a human IgG1 monoclonal antibody, neutralizes multiple influenza A strains and protects mice from H1N1.</p>Forma y color:LiquidGedivumab
CAS:<p>Gedivumab is a human antibody targeting influenza A, binding to its stem region, inhibiting virus maturation and fusion.</p>Forma y color:LiquidF0045(S)
CAS:<p>F0045(S) serves as an effective inhibitor of influenza hemagglutinin, with a KD value of 6.1 µM. It also protects human cells from influenza infections.</p>Fórmula:C17H15Cl2NO2Forma y color:SolidPeso molecular:336.219(S),12(S),13(S)-TriHOME
CAS:<p>9(S),12(S),13(S)-TriHOME, a linoleic acid oxylipin, has multiple bioactivities; found in plants, made by human eosinophils, inhibits mast cells and microglia.</p>Fórmula:C18H34O5Forma y color:SolidPeso molecular:330.46Salcomine
CAS:<p>Salcomine (NSC-32965) shows anti-influenza virus activity.</p>Fórmula:C16H14CoN2O2Pureza:97.42%Forma y color:Black Crystalline PowderPeso molecular:325.23Camptothecin
CAS:<p>Camptothecin (CPT) belongs to the alkaloid group of natural products and is a specific DNA topoisomerase I (Topo I) inhibitor (IC50=679 nM) with specificity.</p>Fórmula:C20H16N2O4Pureza:99.52% - 99.88%Forma y color:Solid PowderPeso molecular:348.35BMY-27709
CAS:<p>BMY-27709 inhibits influenza growth (IC50: 3-8 μM, A/WSN/33), targets H1/H2 subtypes via hemagglutinin, ineffective against H3/B Lee/40.</p>Fórmula:C17H24ClN3O2Pureza:98.37% - 98.55%Forma y color:SolidPeso molecular:337.84M2 ion channel blocker
CAS:<p>M2 ion channel blocker ,Antiviral agent, is capable of inhibiting and blocking the activity of M2 ion channel.</p>Fórmula:C18H27N3O2Pureza:98%Forma y color:SolidPeso molecular:317.43Cap-dependent endonuclease-IN-26
CAS:<p>Cap-dependent endonuclease-IN-26 inhibits CEN (IC50: 286 nM), has broad antiviral effects on influenza A/B.</p>Fórmula:C23H23N3O3Forma y color:SolidPeso molecular:389.45Cap-dependent endonuclease-IN-8
CAS:<p>Cap-dependent endonuclease-IN-8, from CN111410661A (I-196), inhibits CENs, halting orthomyxovirus replication, like influenza A/B/C.</p>Fórmula:C29H23F2N3O6SForma y color:SolidPeso molecular:579.57Influenza virus-IN-3
CAS:<p>Influenza virus-IN-3 inhibits H5N1, H5N2, H5N6, H5N8 with low toxicity; targets neuraminidase.</p>Fórmula:C25H32N2O4SForma y color:SolidPeso molecular:456.6RSV-IN-4
CAS:<p>RSV-IN-4 is a dual inhibitor for RSV and IAV with an EC50 of 11.76 μM.</p>Fórmula:C18H18N2O2SForma y color:SolidPeso molecular:326.41Neuraminidase-IN-5
CAS:<p>Neuraminidase-IN-5: potent NA inhibitor, IC50=0.02μM, potential anti-influenza, dihydrofurocoumarin derivative.</p>Fórmula:C19H11NO7Forma y color:SolidPeso molecular:365.29Cap-dependent endonuclease-IN-19
CAS:<p>Cap-dependent endonuclease-IN-19, a spirocyclic pyridinone, strongly inhibits influenza A virus RNA polymerase.</p>Fórmula:C28H31N3O4Forma y color:SolidPeso molecular:473.56RSV/IAV-IN-3
CAS:<p>RSV/IAV-IN-3 is a dual inhibitor of RSV (EC50: 2.92μM) and IAV (EC50:1.90μM), blocking virus replication post-entry.</p>Fórmula:C19H19BrN2O3SForma y color:SolidPeso molecular:435.33Ingavirin
CAS:<p>Ingavirin, a novel inhibitor of the influenza virus reproduction, inhubits the formation of the virus specific hemagglutinin.</p>Fórmula:C10H15N3O3Pureza:98%Forma y color:SolidPeso molecular:225.24RSV/IAV-IN-2
CAS:<p>RSV/IAV-IN-2 (compound 14c) is a potent dual RSV/IAV inhibitor with lower toxicity than Ribavirin, promising for research.</p>Fórmula:C19H20N2O3SForma y color:SolidPeso molecular:356.44Neuraminidase-IN-10
CAS:<p>Neuraminidase-IN-10 inhibits flu virus strains H1N1, H5N1, and H5N8 with IC50 values of 2.6, 5.1, and 1.65 nM respectively.</p>Fórmula:C26H34N2O5SForma y color:SolidPeso molecular:486.62FR-198248
CAS:<p>FR-198248, a new anti-influenza agent, shows antiinfluenza virus activity in Madin-Darby canine kidney (MDCK) cells in vitro.</p>Fórmula:C9H10O5Forma y color:SolidPeso molecular:198.17RSV-IN-3
CAS:<p>RSV-IN-3 is a dual RSV/IAV inhibitor with an EC50 of 32.70 μM against RSV.</p>Fórmula:C16H12Cl2N2OSForma y color:SolidPeso molecular:351.25PPQ-581
CAS:<p>PPQ-581 is an anti-flu drug that blocks RNP trafficking and stops virus replication, preventing cell damage.</p>Fórmula:C25H24FN3O3Forma y color:SolidPeso molecular:433.47Influenza virus-IN-2
CAS:<p>Influenza virus-IN-2 (compound 19) has anti-influenza A virus activities that is a potent inhibitor of influenza virus with an CC 50 of 150.85 μM and EC 50 of 2</p>Fórmula:C17H17NO5Forma y color:SolidPeso molecular:315.32RO5464466
CAS:<p>RO5464466 is an inhibitor of influenza A virus (H1N1) fusion.</p>Fórmula:C16H26N2O3SForma y color:SolidPeso molecular:326.45Neuraminidase-IN-3
CAS:<p>Neuraminidase-IN-3 inhibits flu NA: H1N1 IC50=0.73nM, H5N1=0.26nM, H5N8=0.63nM.</p>Fórmula:C27H32N2O4SForma y color:SolidPeso molecular:480.62RSV/IAV-IN-1
CAS:<p>RSV/IAV-IN-1, a dual inhibitor of RSV/IAV, is less toxic than Ribavirin and holds research potential for RSV/IAV infections.</p>Fórmula:C18H17ClN2O2SForma y color:SolidPeso molecular:360.86Cap-dependent endonuclease-IN-3
CAS:<p>Cap-dependent endonuclease-IN-3 inhibits CEN, promising for studying influenza A/B. (Patent WO2019141179A1, compound III-2)</p>Fórmula:C29H25F2N3O7SForma y color:SolidPeso molecular:597.59Cap-dependent endonuclease-IN-21
CAS:<p>Cap-dependent endonuclease-IN-21 inhibits CEN and flu virus replication, potential against influenza A. (From patent WO2021233302A1, compound 8B/8A)</p>Fórmula:C26H23F2N3O7Forma y color:SolidPeso molecular:527.47Enisamium iodide
CAS:<p>Enisamium iodide is used as an antiviral agent.</p>Fórmula:C14H15IN2OForma y color:SolidPeso molecular:354.19Goitrin
CAS:<p>Goitrin, from glucosinolate reactions, blocks thyroid peroxidase and iodine use, and fights H1N1.</p>Fórmula:C5H7NOSForma y color:SolidPeso molecular:129.18Influenza virus-IN-4
CAS:<p>Influenza virus-IN-4 (compound 11e) is a potent inhibitor of influenza virus neuraminidase, acting on H5N1 (IC50: 3.4 μM), H5N2 (IC50: 0.094 μM), H5N6 (IC50: 0.</p>Fórmula:C23H31FN2O4Forma y color:SolidPeso molecular:418.5Neuraminidase-IN-8
CAS:<p>Neuraminidase-IN-8 (Compound 6d) is a powerful inhibitor of neuraminidase, exhibiting a low half-maximal inhibitory concentration (IC50) of 0.027 μM and</p>Fórmula:C18H16FN3O3SForma y color:SolidPeso molecular:373.4Influenza A virus-IN-4
CAS:<p>Influenza A virus-IN-4 (23b), a potent neuraminidase inhibitor derived from Oseltamivir, effectively targets influenza viruses.</p>Fórmula:C19H28N4O4Forma y color:SolidPeso molecular:376.45Cap-dependent endonuclease-IN-16
CAS:<p>Cap-dependent endonuclease-IN-16, a pyridone derivative, inhibits CEN, showing promise for flu research.</p>Fórmula:C28H25F2N3O7SForma y color:SolidPeso molecular:585.58Neuraminidase-IN-9
CAS:<p>Neuraminidase-IN-9 inhibits flu virus neuraminidase H5N1 (IC50: 0.12 μM), H5N2 (IC50: 0.049 μM), H5N6 (IC50: 0.16 μM).</p>Fórmula:C24H33BrN6O3Forma y color:SolidPeso molecular:533.46Influenza virus-IN-1
CAS:<p>Influenza virus-IN-1, a potent anti-influenza A compound, has CC50 >200 μM, EC50 2.46 μM, and inhibits PAN endonuclease (EC50 312.36 nM).</p>Fórmula:C16H17NO5Forma y color:SolidPeso molecular:303.31Cap-dependent endonuclease-IN-23
CAS:<p>Cap-dependent endonuclease-IN-23 hinders influenza virus replication by inhibiting CEN, with potential for flu research.</p>Fórmula:C26H23F2N3O7Forma y color:SolidPeso molecular:527.47Neuraminidase-IN-6
CAS:<p>Neuraminidase-IN-6, a 1,3,4-triazole derivative, is a strong NA inhibitor (IC50 = 0.11 μM) used in anti-influenza drug development.</p>Fórmula:C16H16N4O2SForma y color:SolidPeso molecular:328.39Caprochlorone
CAS:<p>Caprochlorone fights orthopoxvirus, lowers influenza in mice lungs, blocks virus entry, and delays its release from cells.</p>Fórmula:C19H19ClO3Forma y color:SolidPeso molecular:330.81Influenza virus-IN-5
CAS:<p>Influenza virus-IN-5 (Compound 5f) is an influenza virus hemagglutinin (HA) inhibitor that acts on the A/H3N2 virus (EC50: 1 nM).</p>Fórmula:C21H26ClN3O2SForma y color:SolidPeso molecular:419.97MBX2546
CAS:MBX2546, an influenza A inhibitor, stops HA-induced membrane fusion by binding and stabilizing HA. Resistant virus mutations occur near HA2 start.Fórmula:C18H21N3O5SPureza:98%Forma y color:SolidPeso molecular:391.44BMS-199945
CAS:<p>BMS-199945 is an Influenza H1N1 Virus inhibitor.</p>Fórmula:C18H27NO2Pureza:98%Forma y color:SolidPeso molecular:289.412,3-Dehydro-2-Deoxy-N-Acetylneuraminic Acid
CAS:<p>2,3-Dehydro-2-Deoxy-N-Acetylneuraminic Acid is a pan-sialidase (neuraminidase, NEU) inhibitor with inhibitory activity and against various influenza viruses.</p>Fórmula:C11H17NO8Forma y color:SolidPeso molecular:291.26Neuraminidase-IN-13
CAS:<p>Neuraminidase-IN-13 (Compound 10), a neuraminidase inhibitor exhibiting antiviral activity, demonstrates significant inhibition of NDV infection in Vero cells</p>Fórmula:C13H13F7N4O7Pureza:98%Forma y color:SolidPeso molecular:470.25Anti-Influenza agent 4
CAS:<p>Anti-Influenza agent 4 selectively inhibits A/Parma (EC50: 62 nM) and A/Roma (EC50: 150 nM) influenza strains.</p>Fórmula:C19H18N2O5SPureza:98.94% - 98.95%Forma y color:SolidPeso molecular:386.42NS1-IN-1
CAS:<p>NS1-IN-1: Potent NS1 inhibitor, antiviral, reduces viral proteins by inhibiting mTORC1 via TSC1-TSC2, limits replication.</p>Fórmula:C23H26N2O4Pureza:98.71%Forma y color:SolidPeso molecular:394.46Laninamivir Octanoate Monohydrate
CAS:<p>Laninamivir Octanoate Monohydrate is a neuraminidase inhibitor.</p>Fórmula:C21H38N4O9Pureza:98%Forma y color:SolidPeso molecular:490.55(Rac)-CP-609754
CAS:<p>LNK754 is a farnesyltransferase inhibitor. It is used for the treatment of cancer and Alzheimer's disease.</p>Fórmula:C29H22ClN3O2Pureza:98%Forma y color:SolidPeso molecular:479.96Antiviral agent 43
CAS:<p>Antiviral agent 43 (compound 16) serves as a potent, orally active inhibitor of influenza A virus entry, demonstrating efficacy by inhibiting the replication of the influenza A strains VH04-H5N1 and PR8-H1N1 with EC50 values of 240 nM and 72 nM, respectively [1].</p>Fórmula:C17H22ClF3N2OForma y color:SolidPeso molecular:362.82Cap-dependent endonuclease-IN-13
CAS:<p>Cap-dependent endonuclease-IN-13 is a potent inhibitor of cap-dependent endonuclease (CEN) and shows research potential against influenza virus infection (</p>Fórmula:C25H20F2N4O4SForma y color:SolidPeso molecular:510.51Influenza virus-IN-6
CAS:<p>Influenza virus-IN-6 (Compound 35) serves as a potent inhibitor targeting the N-terminal domain of the polymerase acidic protein (PA N ) endonuclease subunit of</p>Fórmula:C27H26ClNO7Pureza:98%Forma y color:SolidPeso molecular:511.95L-742001 Hydrochloride
CAS:<p>L-742001 Hydrochloride is an RNA polymerase inhibitor.</p>Fórmula:C23H25Cl2NO4Forma y color:SolidPeso molecular:450.36DU-34569 Maleate
CAS:<p>DU-34569 Maleate, an antiviral agent, acts against influenza A, parainfluenza Sendai, coxsackie A21, and rhinovirus.</p>Fórmula:C18H27NO4Pureza:98%Forma y color:SolidPeso molecular:321.41RO-7
CAS:<p>RO-7 is a next-generation polymerase (PA) endonuclease influenza A and B viruses inhibitor.</p>Fórmula:C24H20F3N3O3SPureza:98%Forma y color:SolidPeso molecular:487.49JNJ4796
CAS:<p>JNJ4796 is an oral fusion inhibitor that neutralizes influenza A group 1 by blocking HA-mediated fusion, mimicking bnAbs.</p>Fórmula:C28H27N9O3Pureza:98%Forma y color:SolidPeso molecular:537.57Tirfipiravir
CAS:<p>Tirapiravir is an antiviral nucleoside analog that exhibits activity against both the novel coronavirus and influenza virus [1].</p>Fórmula:C14H17N3O8Pureza:98%Forma y color:SolidPeso molecular:355.3EHNA hydrochloride
CAS:<p>EHNA hydrochloride is a PDE2 and ADA inhibitor with anticancer activity, increasing intracellular adenosine concentration in a treatment time-dependent manner.</p>Fórmula:C14H24ClN5OPureza:98%Forma y color:SolidPeso molecular:313.83Antiviral agent 35
CAS:<p>Antiviral agent 35 (compound 4d) serves as a potent orally active inhibitor of the influenza virus, targeting early stages of viral replication.</p>Fórmula:C23H18N2O4SPureza:98%Forma y color:SolidPeso molecular:418.47XSJ2-46
CAS:<p>XSJ2-46, a 5'-amino NI analog, is an antiviral agent possessing anti-Zika virus properties and demonstrates reasonable inhibition of RNA-dependent RNA</p>Fórmula:C25H24ClF3N6O3Pureza:98%Forma y color:SolidPeso molecular:548.953,4'-Dihydroxyflavone
CAS:<p>3,4'-Dihydroxyflavone (3,4'-DHF) is an oral active flavonoid. 3,4'-Dihydroxyflavone (3,4'-DHF) shows antiviral activity against Influenza A virus.</p>Fórmula:C15H10O4Pureza:98.33%Forma y color:SolidPeso molecular:254.243M-011
CAS:<p>3M-011: potent TLR7/8 agonist, cytokine inducer, enhances radiotherapy, fights H3N2, and has anti-tumor effects.</p>Fórmula:C18H25N5O3SPureza:98%Forma y color:SolidPeso molecular:391.49EBOV-IN-1
CAS:<p>EBOV-IN-1 is an adamantane dipeptide piperazine inhibitor of Ebola virus (EBOV) that inhibits EBOV infection and suppresses pseudotypic EBOV infection.</p>Fórmula:C34H43N3O5Pureza:98.62% - 98.92%Forma y color:SolidPeso molecular:573.72Massarilactone H
CAS:<p>Massarilactone H, a polyketide, is a neuraminidase inhibitor, with an IC 50 of 8.18 µM .</p>Fórmula:C11H12O5Forma y color:SolidPeso molecular:224.21Flutimide
CAS:<p>Flutimide: Endonuclease inhibitor, IC50 = 3μM, for research on acute respiratory diseases like influenza.</p>Fórmula:C12H18N2O3Forma y color:SolidPeso molecular:238.28Saussureamine C
CAS:<p>Saussureamine C is an inhibitor of H274Y and N294S mutants.</p>Fórmula:C19H26N2O5Forma y color:SolidPeso molecular:362.42Neuraminidase-IN-11
<p>Neuraminidase-IN-11 (15e) inhibits H1N1 (IC50: 4.7nM), H5N1 (8.46nM), H5N8 viruses (1.5nM) selectively & potently.</p>Forma y color:SolidNeuraminidase-IN-4
<p>Neuraminidase-IN-4 inhibits neuraminidase (EC50: 1.59 μM) and has strong anti-H5N1 activity.</p>Fórmula:C21H20N2O6SForma y color:SolidPeso molecular:428.46Carbodine
CAS:<p>Carbodine is an antiviral targeting CTP synthetase, effective against influenza A0/PR-8/34 and A2/Aichi/2/68.</p>Fórmula:C10H15N3O4Pureza:98%Forma y color:SolidPeso molecular:241.24RdRP-IN-5
CAS:<p>RdRP-IN-5 (compound 20), a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), has potential application in influenza research [1].</p>Fórmula:C23H21N3O5Pureza:98%Forma y color:SolidPeso molecular:419.43Cap-dependent endonuclease-IN-17
CAS:<p>CEN inhibitor IN-17 targets influenza A/H3N2; IC50: 1.29 μM. From patent CN112898346A, DSC701.</p>Fórmula:C24H20F2N3O7PSForma y color:SolidPeso molecular:563.47UNC0638 hydrate
CAS:<p>UNC0638 hydrate selectively inhibits G9a and GLP histone methyltransferases with IC50 values of 15 nM and 19 nM, respectively. It is effective in inhibiting invasion and migration of TNBC cells in vitro. Additionally, UNC0638 hydrate acts as an inhibitor of EHMT1/2 and induces the expression of fetal hemoglobin (HbF) in cultures of human erythroid progenitor cells. Furthermore, it exhibits antiviral activity against FMDV (foot-and-mouth disease virus) and VSV (vesicular stomatitis virus), demonstrating remarkable potency and selectivity across various epigenetic and non-epigenetic targets.</p>Fórmula:C30H49N5O3Forma y color:SolidPeso molecular:527.74Laninamivir trifluoroacetate
CAS:<p>Laninamivir trifluoroacetate, a long-acting antiviral, treats and prevents Influenza A and B via nasal spray.</p>Fórmula:C15H23F3N4O9Pureza:98%Forma y color:SolidPeso molecular:460.363Neuraminidase-IN-18
CAS:<p>Neuraminidase-IN-18 (compound N5), a novel polyheterocyclic neuraminidase (NA) inhibitor, demonstrates significant inhibitory activity against H5N1 NA, with an IC 50 of 0.14 μM against the wild-type H5N1 NA and 0.27 μM against the H5N1-H274Y mutant NA. This compound effectively binds to NAs, inhibiting influenza virus replication at the cellular level [1].</p>Fórmula:C22H18FN3O3SForma y color:SolidPeso molecular:423.46AV-5080
CAS:<p>AV-5080 is an orally active neuraminidase (neuraminidase) inhibitor that is utilized in the research of both Type A and Type B influenza viruses.</p>Fórmula:C15H25FN4O4Forma y color:SolidPeso molecular:344.38VV261
CAS:<p>VV261 is an orally active inhibitor of the Influenza Virus. It exhibits activity against the Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) and the Lymphocytic Choriomeningitis Virus (LCMV), with EC50 values of 0.89 and 0.15, respectively.</p>Fórmula:C28H34FN3O11Forma y color:SolidPeso molecular:607.58Cap-dependent endonuclease-IN-5
CAS:<p>Cap-dependent endonuclease-IN-5 inhibits CEN and fights influenza with low toxicity and good in vivo properties.</p>Fórmula:C27H21F2N3O4S2Forma y color:SolidPeso molecular:553.60cis-RdRP-IN-5
<p>Cis-RdRP-IN-5 is an effective inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), employed in influenza virus research.</p>Fórmula:C23H21N3O5Forma y color:SolidPeso molecular:419.43Anti-Influenza agent 3
<p>Compound 11h: Potent, low-toxicity anti-influenza, inhibits M2 ion channels. EC50: 3.29μM (H3N2), 2.45μM (H1N1).</p>Fórmula:C16H22ClNOSForma y color:SolidPeso molecular:311.87Cap-dependent endonuclease-IN-10
CAS:<p>Cap-dependent endonuclease-IN-10, with low toxicity & good stability, effectively inhibits flu viruses and shows promise against A, B, C types.</p>Fórmula:C25H18F2N4O5SForma y color:SolidPeso molecular:524.50Cap-dependent endonuclease-IN-2
<p>Cap-dependent endonuclease-IN-2 strongly blocks influenza A virus RNA polymerase; it's a CEN inhibitor.</p>Fórmula:C30H24FN3O7SForma y color:SolidPeso molecular:589.59RdRP-IN-4
<p>RdRP-IN-4, an oral arylbenzohydrazide, inhibits influenza A/B by targeting PB1 of RdRP, with EC50s of 53 nM (H1N1) and 20 nM (Flu B), and aids infected mice.</p>Fórmula:C17H17Br2N3O2Forma y color:SolidPeso molecular:455.14Cap-dependent endonuclease-IN-6
CAS:<p>Cap-dependent endonuclease-IN-6 (compound 13) is a Cap-dependent endonuclease (CEN) inhibitor that inhibits influenza virus.</p>Fórmula:C23H21N3O3SForma y color:SolidPeso molecular:419.5trans-RdRP-IN-5
<p>Trans-RdRP-IN-5 is a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), with applications in influenza virus research.</p>Fórmula:C23H21N3O5Forma y color:SolidPeso molecular:419.43Cap-dependent endonuclease-IN-7
CAS:<p>Cap-dependent endonuclease-IN-7, a potent CEN inhibitor, blocks viral mRNA synthesis and virus spread, with research use for influenza A, B, C.</p>Fórmula:C36H28FN3O7SForma y color:SolidPeso molecular:665.69Cap-dependent endonuclease-IN-14
CAS:<p>Cap-dependent endonuclease-IN-14 hinders CEN and could treat influenza virus infections. (Patent CN113620948A, compound 1-c).</p>Fórmula:C30H23FN2O6SForma y color:SolidPeso molecular:558.58Cap-dependent endonuclease-IN-25
CAS:<p>Cap-dependent endonuclease-IN-25 is a potent inhibitor of CEN, useful in studying Orthomyxoviridae viruses. (See WO2020075080A1, compound 4.)</p>Fórmula:C25H25N3O3Forma y color:SolidPeso molecular:415.48Cap-dependent endonuclease-IN-1
CAS:<p>Cap-dependent endonuclease-IN-1: potent, oral inhibitor with antiviral properties against influenza.</p>Fórmula:C27H22F2N2O6SPureza:98.88% - 99.09%Forma y color:SolidPeso molecular:540.54UH15-38
CAS:<p>UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation.</p>Fórmula:C26H27N5O2Pureza:99.85%Forma y color:SolidPeso molecular:441.53FGI-106 tetrahydrochloride
CAS:<p>FGI-106 tetrahydrochloride demonstrates potent inhibitory activity across a broad spectrum of viruses, including those causing hemorrhagic fevers such as Ebola</p>Fórmula:C28H42Cl4N6Pureza:99.68%Forma y color:SolidPeso molecular:604.48Cap-dependent endonuclease-IN-9
CAS:<p>Cap-dependent endonuclease-IN-9, a strong influenza inhibitor, shows low toxicity, good pharmacokinetics, and dynamic action.</p>Fórmula:C29H22F2N4O7SPureza:98%Forma y color:SolidPeso molecular:608.57Ref: TM-T72125
Producto descatalogado
